Search - tctmd.com

Displaying 381 - 400 of 735

Sort: Relevancy | Date

Spin to Win: Results From Late Breaking Meeting Trials Often Overstated

News Daily News

Spin to Win: Results From Late-Breaking Meeting Trials Often Overstated

May 15, 2018

Botox Injections Around the Heart Have Lasting Impact on Suppressing A-fib After CABG

News Conference News HRS 2018

Botox Injections Around the Heart Have Lasting Impact on Suppressing A-fib After CABG

May 14, 2018

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

News Features

To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death

May 02, 2018

Valve-in-Valve TAVR: Mortality, Adverse Events Similar to Redo Surgery at 30 Days

News Daily News

Valve-in-Valve TAVR: Mortality, Adverse Events Similar to Redo Surgery at 30 Days

Yael L. Maxwell

April 25, 2018

Women With MI Less Likely Than Men to Fill Prescription for High-Intensity Statins

News Daily News

Women With MI Less Likely Than Men to Fill Prescription for High-Intensity Statins

Michael O'Riordan

April 16, 2018

Impella Use in Acute MI and Cardiogenic Shock: Clues From US Registry Data

News Daily News

Impella Use in Acute MI and Cardiogenic Shock: Clues From US Registry Data

April 12, 2018

Rates of Heart Failure After Acute MI Declining, Statewide Analysis Shows

News Daily News

Rates of Heart Failure After Acute MI Declining, Statewide Analysis Shows

Michael O'Riordan

April 05, 2018

One in Three Cardiac Patients Use Complementary Health, Often Unbeknownst to Their Doctors

News Daily News

One in Three Cardiac Patients Use Complementary Health, Often Unbeknownst to Their Doctors

Yael L. Maxwell

April 05, 2018

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

News Features

ISCHEMIA Fracas: Amid Charges of Moving the Goalposts, Investigators Come Out Swinging

Michael O'Riordan

March 23, 2018

Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial

News Conference News ACC 2018

Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial

March 14, 2018

Low-Dose, Three-Drug Polypill TRIUMPHs for Blood Pressure

News Conference News ACC 2018

Low-Dose, Three-Drug Polypill TRIUMPHs for Blood Pressure

March 12, 2018

Mixing Haircuts and Hypertension Rx a ‘Home Run’ for Blood Pressure Control

News Conference News ACC 2018

Mixing Haircuts and Hypertension Rx a ‘Home Run’ for Blood Pressure Control

March 12, 2018

ACC 2018, Day Three: Gout, Hypertension, and Diabetes Dominate Opening Late Breaker

News Conference News ACC 2018

ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More

March 12, 2018

Despite Increasing Access to Invasive Cardiac Care, Rural Patients Still at a Disadvantage

News Daily News

Despite Increasing Access to Invasive Cardiac Care, Rural Patients Still at a Disadvantage

February 09, 2018

Most Stroke Thrombectomies Performed by Dedicated Neurointerventionalists

News Conference News ISC 2018

Most Stroke Thrombectomies Performed by Dedicated Neurointerventionalists

February 02, 2018

More Stroke Thrombectomy Studies Offer Insights Into Subgroups, New Devices, and Lytic Choice

News Conference News ISC 2018

More Stroke Thrombectomy Studies Offer Insights Into Subgroups, New Devices, and Lytic Choice

January 31, 2018

Multivessel Disease Patients See Benefits of Long-term Ticagrelor: PEGASUS-TIMI 54 Analysis

News Daily News

Multivessel Disease Patients See Benefits of Long-term Ticagrelor: PEGASUS-TIMI 54 Analysis

Yael L. Maxwell

January 31, 2018

Experts Debate: Is It ‘Nuts’ to Restart Anticoagulation After Lobar ICH?

News Conference News ISC 2018

Experts Debate: Is It ‘Nuts’ to Restart Anticoagulation After Lobar ICH?

January 30, 2018

Ischemic Stroke Risk After Acute MI May Last Longer Than Previously Thought

News Conference News ISC 2018

Ischemic Stroke Risk After Acute MI May Last Longer Than Previously Thought

January 29, 2018

News Industry News

New Real-World Analysis Finds Lower Risk of Major Bleeding and Similar Risk of Stroke with Standard Dose of Pradaxa® Compared to Rivaroxaban in NVAF Patients Newly Initiating Treatment

January 29, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.